Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab von Yamauchi, Ichiro, Yasoda, Akihiro, Matsumoto, Shigemi, Sakamori, Yuichi, Kim, Young Hak, Nomura, Motoo, Otsuka, Atsushi, Yamasaki, Toshinari, Saito, Ryoichi, Kitamura, Morimasa, Kitawaki, Toshio, Hishizawa, Masakatsu, Kawaguchi-Sakita, Nobuko, Fujii, Toshihito, Taura, Daisuke, Sone, Masakatsu, Inagaki, Nobuya

Volltext

Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial von Akamatsu, Hiroaki, Katakami, Nobuyuki, Okamoto, Isamu, Kato, Terufumi, Kim, Young Hak, Imamura, Fumio, Shinkai, Masaharu, Hodge, Rachel A., Uchida, Hirohiko, Hida, Toyoaki

Volltext

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients von Nomizo, Takashi, Ozasa, Hiroaki, Tsuji, Takahiro, Funazo, Tomoko, Yasuda, Yuto, Yoshida, Hironori, Yagi, Yoshitaka, Sakamori, Yuichi, Nagai, Hiroki, Hirai, Toyohiro, Kim, Young Hak

Volltext

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation von Tsuji, Takahiro, Ozasa, Hiroaki, Aoki, Wataru, Aburaya, Shunsuke, Yamamoto Funazo, Tomoko, Furugaki, Koh, Yoshimura, Yasushi, Yamazoe, Masatoshi, Ajimizu, Hitomi, Yasuda, Yuto, Nomizo, Takashi, Yoshida, Hironori, Sakamori, Yuichi, Wake, Hiroaki, Ueda, Mitsuyoshi, Kim, Young Hak, Hirai, Toyohiro

Volltext

MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression von Yasuda, Yuto, Ozasa, Hiroaki, Kim, Young Hak, Yamazoe, Masatoshi, Ajimizu, Hitomi, Yamamoto Funazo, Tomoko, Nomizo, Takashi, Tsuji, Takahiro, Yoshida, Hironori, Sakamori, Yuichi, Nakajima, Naoki, Menju, Toshi, Yoshizawa, Akihiko, Date, Hiroshi, Hirai, Toyohiro

Volltext

Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer von Kim, Young Hak, Ishii, Genichiro, Goto, Koichi, Ota, Shuji, Kubota, Kaoru, Murata, Yukinori, Mishima, Michiaki, Saijo, Nagahiro, Nishiwaki, Yutaka, Ochiai, Atsushi

Volltext

Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature von Togashi, Yosuke, Masago, Katsuhiro, Hamatani, Yasuhiro, Sakamori, Yuichi, Nagai, Hiroki, Kim, Young Hak, Mishima, Michiaki

Volltext

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease von Kanai, Osamu, Kim, Young Hak, Demura, Yoshiki, Kanai, Makiko, Ito, Tsuyoshi, Fujita, Kohei, Yoshida, Hironori, Akai, Masaya, Mio, Tadashi, Hirai, Toyohiro

Volltext

Second-line chemotherapy for small-Cell Lung Cancer (SCLC) von Kim, Young Hak, Mishima, Michiaki

Volltext

Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab von Funazo, Tomoko Yamamoto, Nomizo, Takashi, Ozasa, Hiroaki, Tsuji, Takahiro, Yasuda, Yuto, Yoshida, Hironori, Sakamori, Yuichi, Nagai, Hiroki, Hirai, Toyohiro, Kim, Young Hak

Volltext

Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy von Hatae, Ryusuke, Chamoto, Kenji, Kim, Young Hak, Sonomura, Kazuhiro, Taneishi, Kei, Kawaguchi, Shuji, Yoshida, Hironori, Ozasa, Hiroaki, Sakamori, Yuichi, Akrami, Maryam, Fagarasan, Sidonia, Masuda, Izuru, Okuno, Yasushi, Matsuda, Fumihiko, Hirai, Toyohiro, Honjo, Tasuku

Volltext

Maintenance chemotherapy for non-small-cell lung cancer von Kim, Young Hak, Mishima, Michiaki

Volltext

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer von Kim, Young Hak, Yoh, Kiyotaka, Niho, Seiji, Goto, Koichi, Ohmatsu, Hironobu, Kubota, Kaoru, Nishiwaki, Yutaka

Volltext

Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer von Tsuji, Takahiro, Sakamori, Yuichi, Ozasa, Hiroaki, Yagi, Yoshitaka, Ajimizu, Hitomi, Yasuda, Yuto, Funazo, Tomoko, Nomizo, Takashi, Yoshida, Hironori, Nagai, Hiroki, Maeno, Ken, Oguri, Tetsuya, Hirai, Toyohiro, Kim, Young Hak

Volltext

肺癌治療における免疫療法の射程と解決すべき課題 von 金, 永学

Volltext

Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor von Fujita, Kohei, Kim, Young Hak, Yoshizawa, Akihiko, Mio, Tadashi, Mishima, Michiaki

Volltext

Rapidly progressive sarcomatoid malignant mesothelioma of the pleura mimicking pulmonary empyema von Fujita, Kohei, Kim, Young Hak, Nakatani, Koichi, Mio, Tadashi

Volltext

Successful treatment with carboplatin and etoposide in a small-cell lung cancer patient undergoing hemodialysis von Kim, Young Hak, Mio, Tadashi, Hamamoto, Yumi, Mishima, Michiaki

Volltext

沈香의 항알레르기 效果에 대한 硏究 von 金永學(Kim Young Hak), 李彦政(Lee Eon Jeong), 宋峰根(Song Bong Keun), 金炯均(Kim Hyeong Kyun)

Volltext